1
|
Gubanova MV, Kalashnikova LA, Dobrynina LA. [Fibromuscular dysplasia and its neurological manifestations]. Zh Nevrol Psikhiatr Im S S Korsakova 2020; 120:116-123. [PMID: 33340306 DOI: 10.17116/jnevro2020120111116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The authors present the current data on the classification, epidemiology, etiology, neurological manifestations, prognosis, diagnosis, and treatment of patients with fibromuscular dysplasia (FMD). The review is based on the selection of publications by searching PubMed for keywords from the first sources until March 2019. FMD is a segmental non-atherosclerotic and non-inflammatory disease of large- and medium-caliber arteries leading to their stenosis. The disease occurs mostly in women (90%), and manifests itself in the 5th decade of life. In the cerebrovascular form of FMD, the extracranial internal carotid artery and the vertebral artery are usually affected. Diagnosis is based on the identification of alternation of narrowing and dilation of arteries using angiography (the string of beads sign (multifocal form)). Neurological manifestations include headache, tinnitus, and ischemic stroke, usually due to the dissection or stenosis, rarely, intracerebral or subarachnoid hemorrhages. The prognosis in most cases is favorable, relapses of strokes are rare. Treatment includes antiplatelet agents, if they are ineffective to prevent recurrence of ischemic stroke, endovascular treatment is carried out. Approaches to the treatment of intracranial aneurysms do not differ from those in patients without FMD.
Collapse
|
2
|
Touzé E, Southerland AM, Boulanger M, Labeyrie PE, Azizi M, Bouatia-Naji N, Debette S, Gornik HL, Hussain SM, Jeunemaitre X, Joux J, Kirton A, Le Hello C, Majersik JJ, Mocco J, Persu A, Sharma A, Worrall BB, Olin JW, Plouin PF. Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review. JAMA Neurol 2019; 76:217-226. [PMID: 30285053 DOI: 10.1001/jamaneurol.2018.2848] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Importance Data on neurologic manifestations of fibromuscular dysplasia (FMD) are rare, and current knowledge remains limited. Objectives To present a comprehensive review of the epidemiologic characteristics, management, and prognosis of the neurologic manifestations associated with cerebrovascular FMD (ie, involving cervical or intracranial arteries) and to guide future research priorities. Evidence Review References were identified through searches of PubMed from inception to December 2017 using both the medical subject headings and text words. Additional sources were also identified by reviewing reference lists of relevant articles and through searches of the authors' personal files. Selected articles described at least 1 clinical or radiologic feature and/or outcome of cerebrovascular FMD. Isolated case reports could be included if they described interesting or noteworthy manifestations of FMD. Findings A total of 84 relevant references were identified. Diagnosis of cerebrovascular FMD is based on the appearance of alternating arterial dilatation and constriction ("string of beads") or of focal narrowing, with no sign of atherosclerotic or inflammatory lesions. Although the diagnosis is easily apparent on results of radiographic imaging, making a diagnosis can be challenging in children or individuals with atypical phenotypes, such as purely intracranial FMD and arterial diaphragm. Involvement of multiple arteries is common, and there is increased incidence of cervical artery dissection and intracranial aneurysms. A variant in the PHACTR1 gene has been associated with FMD as well as cervical artery dissection and migraine, although less than 5% of cases of FMD are familial. Headaches, mainly of the migraine type, are observed in up to 70% of patients with FMD. Cerebrovascular FMD is mostly asymptomatic, but the most frequent neurologic manifestations include transient ischemic attack and ischemic stroke, notably in the presence of associated cervical artery dissection. Other conditions associated with FMD include subarachnoid hemorrhage and, rarely, intracranial hemorrhage. Management relies on observational data and expert opinion. Antiplatelet therapy is considered reasonable to prevent thromboembolic complications. Endovascular therapy is typically restricted to cases with symptomatic stenosis despite optimal medical therapy or in those with rupture of an intracranial aneurysm. Conclusions and Relevance Longitudinal cohort studies of individuals of multiple ethnicities with biosampling are needed to better understand the risk factors, pathophysiological features, and outcomes of FMD. Patient advocacy groups could assist researchers in answering patient-centered questions regarding FMD.
Collapse
Affiliation(s)
- Emmanuel Touzé
- Normandie Université, Université Caen Normandie, Institut National de la Santé et de la Recherche Médicale U1237, Centre Hospitalier et Universitaire Caen, Caen, France
| | - Andrew M Southerland
- Department of Neurology, University of Virginia Health System, Charlottesville.,Department of Public Health Sciences, University of Virginia Health System, Charlottesville
| | - Marion Boulanger
- Normandie Université, Université Caen Normandie, Institut National de la Santé et de la Recherche Médicale U1237, Centre Hospitalier et Universitaire Caen, Caen, France
| | - Paul-Emile Labeyrie
- Normandie Université, Université Caen Normandie, Institut National de la Santé et de la Recherche Médicale U1237, Centre Hospitalier et Universitaire Caen, Caen, France.,Department of Radiology, University of Lyon, Hôpitaux de Lyon, Lyon, France
| | - Michel Azizi
- Paris-Descartes University, Institut National de la Santé et de la Recherche Médicale UMR970, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France
| | - Nabila Bouatia-Naji
- Paris-Descartes University, Institut National de la Santé et de la Recherche Médicale UMR970, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France
| | - Stéphanie Debette
- Department of Neurology, Memory Clinic, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France.,Institut National de la Santé et de la Recherche Médicale U1219, Bordeaux Population Health Research Center, Bordeaux, France
| | | | | | - Xavier Jeunemaitre
- Paris-Descartes University, Institut National de la Santé et de la Recherche Médicale UMR970, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France
| | - Julien Joux
- Department of Neurology, Centre Hospitalier et Universitaire Fort-de-France, Martinique, French West Indies
| | - Adam Kirton
- Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada
| | - Claire Le Hello
- Normandie Université, Université Caen Normandie, Institut National de la Santé et de la Recherche Médicale U1237, Centre Hospitalier et Universitaire Caen, Caen, France.,Service de Médecine Vasculaire, Université de Saint-Etienne, Centre Hospitalier et Universitaire Saint-Etienne, Saint-Etienne, France
| | | | - J Mocco
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Alexandre Persu
- Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium.,Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Aditya Sharma
- Department of Medicine, University of Virginia Health System, Charlottesville
| | - Bradford B Worrall
- Department of Neurology, University of Virginia Health System, Charlottesville.,Department of Public Health Sciences, University of Virginia Health System, Charlottesville
| | - Jeffrey W Olin
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Pierre-François Plouin
- Paris-Descartes University, Institut National de la Santé et de la Recherche Médicale UMR970, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France
| |
Collapse
|
3
|
Harriott AM, Zimmerman E, Singhal AB, Jaff MR, Lindsay ME, Rordorf GA. Cerebrovascular fibromuscular dysplasia: The MGH cohort and literature review. Neurol Clin Pract 2017; 7:225-236. [PMID: 28680766 DOI: 10.1212/cpj.0000000000000339] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2016] [Accepted: 11/28/2016] [Indexed: 11/15/2022]
Abstract
BACKGROUND Fibromuscular dysplasia (FMD) is a rare noninflammatory, nonatherosclerotic arteriopathy of medium-sized arteries affecting up to 7% of the population. The disease can affect any artery but commonly affects renal, extracranial carotid, and vertebral arteries. The epidemiology and natural course of cerebrovascular FMD is unknown and requires further investigation. METHODS We present demographic and outcomes data on a case series of 81 patients with cerebrovascular FMD from Massachusetts General Hospital presenting between 2011 and 2015 followed by a review of the peer-reviewed literature. RESULTS Patients were a median age of 53 years (±12 SD) and the majority were women. Approximately 50% had a history of tobacco use and more than two-thirds had hypertension. Most patients were on monoplatelet therapy with aspirin; during follow-up, 7 of 67 had progressive disease or additional symptoms. One of 67 patients had a cerebrovascular event: TIA. There were 5 of 67 who had noncerebrovascular events or disease progression and 1 death of unclear cause. CONCLUSIONS Cerebrovascular FMD may present with myriad symptoms. Our data support that patients with FMD with symptomatic disease have a low rate of recurrent symptoms or disease progression and can be managed conservatively with stroke risk modification, antiplatelet agents, surveillance imaging, and counseling.
Collapse
Affiliation(s)
- Andrea M Harriott
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| | - Eli Zimmerman
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| | - Aneesh B Singhal
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| | - Michael R Jaff
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| | - Mark E Lindsay
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| | - Guy A Rordorf
- Department of Neurology (AMH, EZ, ABS, GAR), The Fireman Vascular Center (MRJ), and Thoracic Aortic Center and Cardiovascular Research Center (MEL), Massachusetts General Hospital; John R. Graham Headache Center (AMH), Brigham and Women's Faulkner Hospital, Boston; and Department of Neurology (EZ), Vanderbilt University Medical Center, Nashville, TN
| |
Collapse
|
4
|
Yoshida S, Eguchi K, Onodera K, Suzuki K, Fujishiro K, Riku S. [Bilateral internal carotid artery occlusion and severe basilar artery stenosis in a patient with fibromuscular dysplasia: a case report]. Rinsho Shinkeigaku 2013; 53:439-45. [PMID: 23782821 DOI: 10.5692/clinicalneurol.53.439] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory arterial disease of unknown etiology. We report a 26-year-old woman who presented with transient ischemic attack (TIA) due to bilateral internal carotid artery (ICA) occlusion and severe basilar artery stenosis, as FMD was diagnosed by a biopsy specimen of right ICA. Imaging investigations included magnetic resonance angiography and catheter angiogram without characteristic "string of beads" pattern, before reaching a definitive diagnosis by pathologist. Anti-platelet therapy and bypass surgery of superficial temporal artery-middle cerebral artery revealed no more clinical symptoms. This case of intra- and extra-cranial FMD gives a consideration of such rare disease in the differential diagnosis of TIA or stroke in healthy young patients. The literature of FMD is reviewed including pathological findings.
Collapse
|
5
|
Touzé E, Oppenheim C, Trystram D, Nokam G, Pasquini M, Alamowitch S, Hervé D, Garnier P, Mousseaux E, Plouin PF. Fibromuscular Dysplasia of Cervical and Intracranial Arteries. Int J Stroke 2010; 5:296-305. [DOI: 10.1111/j.1747-4949.2010.00445.x] [Citation(s) in RCA: 121] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Fibromuscular dysplasia is an uncommon, segmental, nonatherosclerotic arterial disease of unknown aetiology. The disease primarily affects women and involves intermediate-sized arteries in many areas of the body, including cervical and intracranial arteries. Although often asymptomatic, fibromuscular dysplasia can also be associated with spontaneous dissection, severe stenosis that compromises the distal circulation, or intracranial aneurysm, and is therefore responsible for cerebral ischaemia or subarachnoid haemorrhage. Fibro-muscular dysplasia affects middle and distal portions of the internal carotid and vertebral arteries, and occasionally, intracranial arteries. Several pathological and angiographic patterns exist. The most frequent pathological type is medial fibromuscular dysplasia, which is associated with the ‘string of beads' angiographic pattern. Unifocal lesions are less common and can be associated with several pathological subtypes. The pathophysiology of the disease is widely unknown. Fibromuscular dysplasia may in fact result from various causes and reflect a non-specific response to different insults. The poor knowledge of the natural history and the lack of randomised trials that compared the different treatment options do not allow any satisfactory judgement to be made regarding the need for or the efficacy of any treatment.
Collapse
Affiliation(s)
| | - Catherine Oppenheim
- Department of Neurology, Université Paris Descartes, Pôle neuroscience, services de Neurologie et de Neuroradiologie, Hôpital Sainte-Anne, Paris, France
| | - Denis Trystram
- Department of Neurology, Université Paris Descartes, Pôle neuroscience, services de Neurologie et de Neuroradiologie, Hôpital Sainte-Anne, Paris, France
| | - Ghislain Nokam
- Department of Neurology, Université Paris Descartes, Pôle neuroscience, services de Neurologie et de Neuroradiologie, Hôpital Sainte-Anne, Paris, France
| | - Marta Pasquini
- Department of Neurology, Université Paris Descartes, Pôle neuroscience, services de Neurologie et de Neuroradiologie, Hôpital Sainte-Anne, Paris, France
| | - Sonia Alamowitch
- Université Pierre et Marie Curie, Service de Neurologie, Hôpital Tenon, Paris, France
| | - Dominique Hervé
- Université Paris Diderot, Service de Neurologie, Hôpital Lariboisière, Paris, France
| | - Pierre Garnier
- Université de Saint-Etienne, Service de Neurologie, Saint-Etienne, France
| | - Elie Mousseaux
- Université Paris Descartes, Service de Radiologie, Hôpital Européen Georges Pompidou, Paris, France
| | - Pierre-François Plouin
- Université Paris Descartes, Unité d'hypertension, Centre National de Référence des Maladies vasculaires rares, Hôpital Européen Georges Pompidou , Paris, France
| |
Collapse
|
6
|
Bhuriya R, Arora R, Khosla S. Fibromuscular dysplasia of the internal carotid circulation: an unusual presentation. Vasc Med 2008; 13:41-3. [DOI: 10.1177/1358863x07085530] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract Fibromuscular dysplasia (FMD) is an arterial disease of unknown etiology. Most often it affects the renal and internal carotid arteries (ICA), although any artery can be involved. Internal carotid arteries are affected in 25–30% of patients. When carotid arteries are involved, cervical segments C1-C2 are most often affected. FMD of intracranial arteries is rare. FMD has been associated with intracranial aneurysms in 7–50% cases, but FMD associated with a giant (> 2.5 cm) intracranial aneurysm is rare. Extracranial internal carotid aneurysms are uncommon, with only 3% caused by FMD. We report a case of intra and extracranial FMD associated with a giant intracranial aneurysm and an aneurysm of the right extracranial ICA.
Collapse
Affiliation(s)
- Rohitkumar Bhuriya
- Chicago Medical School at Rosalind Franklin University, North Chicago, Illinois, USA
| | - Rohit Arora
- Chicago Medical School at Rosalind Franklin University, North Chicago, Illinois, USA
| | - Sandeep Khosla
- Chicago Medical School at Rosalind Franklin University, North Chicago, Illinois, USA
| |
Collapse
|
7
|
Leary MC, Finley A, Caplan LR. Cerebrovascular complications of fibromuscular dysplasia. CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE 2004; 6:237-248. [PMID: 15096316 DOI: 10.1007/s11936-996-0019-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Patients with cerebral ischemia or hemorrhage due to fibromuscular dysplasia (FMD) should be admitted to a monitored hospital bed and receive supportive stroke care. Based on our personal clinical experience, we recommend antiplatelet agents for future stroke prevention in patients with symptomatic FMD. In patients with watershed stroke due to hemodynamically significant FMD, our opinion is that hypertensive, hypervolemic therapy should be initiated immediately. Additionally, we suggest that potential revascularization therapies, such as intraoperative or primary percutaneous angioplasty, should be discussed.
Collapse
Affiliation(s)
- Megan C. Leary
- Division of Stroke and Cerebrovascular Disease, Palmer 125, Department of Neurology
| | | | | |
Collapse
|
8
|
Piechowski-Józwiak B, Bogousslavsky J. Cervicocephalic Fibromuscular Dysplasia. Stroke 2004. [DOI: 10.1016/b0-44-306600-0/50032-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Osawa H, Fukui K, Otsuka G, Hattori KI, Satake T, Miyazaki M. De novo cerebral aneurysms manifesting as repeated subarachnoid hemorrhage and cerebral ischemic stroke--case report. Neurol Med Chir (Tokyo) 2002; 42:391-5. [PMID: 12371596 DOI: 10.2176/nmc.42.391] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A 29-year-old man suffered repeated subarachnoid hemorrhage and cerebral ischemic stroke over a period of 6 years. Cerebral angiography at each episode disclosed development of multiple de novo aneurysms at the bilateral middle cerebral arteries (MCAs), internal carotid arteries, right anterior cerebral artery, and right vertebral artery. Two of the ruptured aneurysms were treated by surgical and endovascular treatment, but he died of the effects of rupture of a de novo right MCA aneurysm. Histological examination at autopsy disclosed marked degenerative changes in all layers of the cerebral vessels, which were probably congenital in origin.
Collapse
Affiliation(s)
- Hirokatsu Osawa
- Department of Neurosurgery, Nagoya Ekisaikai Hospital, Japan
| | | | | | | | | | | |
Collapse
|
10
|
Currie AD, Bentley CR, Bloom PA. Retinal haemorrhage and fatal stroke in an infant with fibromuscular dysplasia. Arch Dis Child 2001; 84:263-4. [PMID: 11207180 PMCID: PMC1718691 DOI: 10.1136/adc.84.3.263] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Non-accidental injury should be suspected and excluded in any infant found to have intracranial and retinal haemorrhage of unknown aetiology. This can be a sensitive issue for both medical staff and parents. We present a case in which the underlying cause of intracranial and retinal haemorrhage was fibromuscular dysplasia. It was a diagnosis made only at postmortem examination and it illustrates the diagnostic difficulty such cases may present.
Collapse
Affiliation(s)
- A D Currie
- Western Eye Hospital, London NW1 5YE, UK.
| | | | | |
Collapse
|
11
|
Demirkaya S, Topcuoglu MA, Vural O. Fibromuscular dysplasia of the basilar artery: a case presenting with vertebrobasilar TIAs. Eur J Neurol 2001; 8:89-90. [PMID: 11509088 DOI: 10.1046/j.1468-1331.2001.00167.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
12
|
Nakamura M, Rosahl SK, Vorkapic P, Förster C, Samii M. De novo formation of an aneurysm in a case of unusual intracranial fibromuscular dysplasia. Clin Neurol Neurosurg 2000; 102:259-264. [PMID: 11154818 DOI: 10.1016/s0303-8467(00)00114-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Intracranial fibromuscular dysplasia (FMD) is a vascular disease of unknown origin occurring predominantly in young women. The internal carotid artery is most often involved, but other cerebral arteries may also be affected. We report the case of a young woman presenting with an unusual angiographic appearance of intracranial FMD of the internal carotid artery (ICA) that could not be categorized into any type of the Osborn-Anderson classification. During follow up the patient presented with an intracerebral and subarachnoid hemorrhage. Repeated angiography revealed multiple aneurysms in the pathologic segment of the vessel. The patient underwent surgical treatment with clipping of the aneurysms, wrapping of the pathologic segment of the ICA and biopsy of the superficial temporal artery. Histopathological sections revealed FMD of the intimal type. alpha(1)-antitrypsin blood levels were normal. Cases of intracranial FMD previously reported in the literature are reviewed and various aspects of this rare disease are discussed.
Collapse
Affiliation(s)
- M Nakamura
- Department of Neurosurgery, Nordstadt Hospital, Haltenhoffstrasse 41, 30167, Hannover, Germany
| | | | | | | | | |
Collapse
|
13
|
DiFazio M, Hinds SR, Depper M, Tom B, Davis R. Intracranial fibromuscular dysplasia in a six-year-old child: a rare cause of childhood stroke. J Child Neurol 2000; 15:559-62. [PMID: 10961798 DOI: 10.1177/088307380001500814] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Intracranial fibromuscular dysplasia is a nonatheromatous angiopathy that most commonly affects adult women and is rarely recognized in children. Symptoms include stroke and headache, although the vasculopathy may be asymptomatic. Diagnosis is based on angiographic appearance, commonly described as a "string of beads." The etiology of intracranial fibromuscular dysplasia is not known, although possible causes include genetic predisposition, trauma, and underlying connective tissue disease. Treatment of intracranial fibromuscular dysplasia is largely supportive once symptoms become manifest. We report a 6-year-old girl who presented to our center for further evaluation of a large left middle cerebral artery distribution infarction. The patient was previously healthy, without known risk factors for stroke. Initial symptoms consisted of a dense global aphasia and a right hemiparesis. On arrival, the patient's aphasia had improved but she continued to have significant deficits in both receptive and expressive language as well as residual right hemiparesis. Magnetic resonance imaging and conventional angiographic studies demonstrated characteristic beading of the distal portion of the left internal carotid artery, as well as the proximal middle cerebral artery. Laboratory evaluation, echocardiogram, and renal ultrasound were normal. The renal vasculature did not demonstrate evidence of intracranial fibromuscular dysplasia. In conclusion, intracranial fibromuscular dysplasia should be considered in the differential diagnosis of childhood stroke. When recognized, other sites of vascular involvement should be sought, and consideration of underlying disorders is important, as connective tissue disorders have been associated with a propensity to develop this vascular abnormality. Careful follow-up is warranted, due to possible progression of disease.
Collapse
Affiliation(s)
- M DiFazio
- Department of Child and Adolescent Neurology, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA
| | | | | | | | | |
Collapse
|
14
|
Hort W, Schwartzkopff B. Anatomie und Pathologie der Koronararterien. PATHOLOGIE DES ENDOKARD, DER KRANZARTERIEN UND DES MYOKARD 2000. [DOI: 10.1007/978-3-642-56944-9_3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
15
|
Abstract
Fibromuscular dysplasia of the carotid artery is uncommon, but not rare. Although the true incidence and prevalence of the disease are not known, reported figures in adults range between 0.6% by angiography and 1.1% at autopsy. Most case reports of stroke caused by carotid fibromuscular dysplasia describe findings in adult subjects, although there are a few reports of the disease in children. In the present case, we describe a 16-year-old boy with fibromuscular dysplasia confined to one internal carotid artery and its branches, and in whom the disease declared itself by stroke. This case serves as a basis for considering diagnostic methods, treatment options, and future research in pediatric patients with cerebrovascular disease caused by fibromuscular dysplasia.
Collapse
Affiliation(s)
- V Puri
- Department of Neurology, University of Louisville School of Medicine, KY, USA
| | | |
Collapse
|